Catalogue number
IHA-011
Introduction
H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin(H) and neuraminidase(N). H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, and influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses.
Description
Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is 70,000 dalton.
Source
Baculovirus Insect Cells.
Physical Appearance
Sterile Filtered colorless solution.
Formulation
The Recombinant H3N2 A/New-York/55/04 solution contains 10mM Sodium phosphate, pH 7.2 and 150mM NaCl.
Stability
H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Do NOT Freeze!
Immunological Activity
Western-Blot 0.1µg -1µg per strip, ELISA 1µg/Well.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Safety Data Sheet
Usage
ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
